## Lambert-Eaton Myasthenic Syndrome (LEMS): Presynaptic Calcium Channel Dysfunction ### Clinical Presentation and Diagnosis **Key Point:** The constellation of: - **Proximal muscle weakness** (hip and knee weakness) - **Hyporeflexia** (diminished reflexes despite muscle strength loss) - **Incremental response on RNS** (pathognomonic for LEMS) - **Lung malignancy** (SCLC in 50–60% of LEMS cases) ...is diagnostic of Lambert-Eaton myasthenic syndrome (LEMS), a paraneoplastic autoimmune disorder. ### Pathophysiology: Presynaptic Calcium Channel Blockade **High-Yield:** In LEMS, IgG autoantibodies target **presynaptic voltage-gated calcium channels (VGCC)**, specifically P/Q-type channels. This causes: 1. **Impaired calcium influx** — VGCCs normally open during the action potential, allowing Ca²⁺ entry into the presynaptic terminal 2. **Reduced acetylcholine release** — Calcium is essential for synaptic vesicle fusion and ACh exocytosis; fewer Ca²⁺ ions → less ACh released per action potential 3. **Decreased safety margin** — The postsynaptic membrane receives subthreshold ACh, causing weakness 4. **Facilitation with repeated stimulation** — High-frequency stimulation opens more VGCCs (despite antibody blockade), allowing greater Ca²⁺ accumulation and more ACh release, paradoxically improving strength ### Why the Incremental Response Occurs **Clinical Pearl:** The **incremental response** (increase in CMAP amplitude with brief high-frequency stimulation) is the electrophysiological hallmark of LEMS and reflects the presynaptic defect: - Initial low-frequency stimulation → minimal ACh release → small CMAP - Brief high-frequency stimulation (10 Hz for 10 sec) → temporal summation of Ca²⁺ in the terminal → increased ACh release → larger CMAP This is the **opposite** of myasthenia gravis, which shows a **decremental response** (postsynaptic exhaustion). ### Comparison: LEMS vs. Myasthenia Gravis | Feature | LEMS | Myasthenia Gravis | |---------|------|-------------------| | **Site of pathology** | Presynaptic (VGCC) | Postsynaptic (AChR) | | **Antibody target** | P/Q-type VGCC | Nicotinic AChR | | **Weakness pattern** | Proximal > distal, improves with use | Ocular/bulbar, fatigues with use | | **Reflex status** | **Diminished or absent** | Normal | | **RNS response** | **Incremental** (↑ CMAP with HFS) | **Decremental** (↓ CMAP with LFS) | | **Associated malignancy** | SCLC (50–60%) | Thymoma (10–15%) | | **Autonomic symptoms** | Dry mouth, constipation, erectile dysfunction | Absent | **Mnemonic:** **LEMS = Lung + Calcium channels** — Think of LEMS with lung cancer and presynaptic calcium dysfunction. ### Mechanism Diagram ```mermaid flowchart TD A[Paraneoplastic IgG antibodies]:::outcome --> B[Bind P/Q-type VGCC on presynaptic terminal]:::action B --> C[Impaired calcium influx during AP]:::action C --> D[Reduced ACh exocytosis]:::action D --> E[Subthreshold EPP at postsynaptic membrane]:::outcome E --> F[Proximal muscle weakness]:::outcome G[High-frequency stimulation]:::action --> H[Temporal summation of Ca2+]:::action H --> I[Increased ACh release]:::action I --> J[Larger CMAP - Incremental response]:::outcome ```
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.